Neoadjuvant nivolumab (N) plus ipilimumab (I) vs chemotherapy (C) in the phase III CheckMate 816 trial

被引：16

作者：

Awad, M. M. ^{[1
]}

Forde, P. M. ^{[2
]}

Girard, N. ^{[3
]}

Spicer, J. D. ^{[4
]}

Wang, C. ^{[5
]}

Lu, S. ^{[6
]}

Mitsudomi, T. ^{[7
]}

Felip, E. ^{[8
]}

Broderick, S. ^{[9
]}

Swanson, S. J. ^{[1
]}

Brahmer, J. R. ^{[2
]}

Kerr, K. M. ^{[10
]}

Saylors, G. ^{[11
]}

Chen, K-N. ^{[12
]}

Cai, J. L. ^{[13
]}

Mahmood, J. ^{[14
]}

Neely, J. ^{[15
]}

Balli, D. ^{[15
]}

Hu, N. ^{[16
]}

Pulla, M. Provencio ^{[17
]}

机构：

[1] Dana Farber Canc Inst, Med Oncol, Boston, MA USA

[2] Johns Hopkins Med, Bloomberge Kimmel Inst Canc Immunotherapy, Sidney Kimmel Comprehens Canc Ctr, Oncol, Baltimore, MD USA

[3] Inst Curie, Inst Thorax Curie Montsouris, Paris, France

[4] McGill Univ, Gen Surg, Hlth Ctr, Montreal, PQ, Canada

[5] Tianjin Med Univ, Tianjin Lung Canc Ctr, Lung Canc, Canc Inst & Hosp, Tianjin, Peoples R China

[6] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai Lung Canc Ctr, Med Oncol, Shanghai, Peoples R China

[7] Kindai Univ, Thorac Surg Dept, Fac Med, Osakasayama, Japan

[8] Vall dHebron Univ Hosp, Vall dHebron Inst Oncol, Med Oncol, Barcelona, Spain

[9] Johns Hopkins Med, Bloomberge Kimmel Inst Canc Immunotherapy, Sidney Kimmel Comprehens Canc Ctr, Gen Thorac Surg, Baltimore, MD USA

[10] Aberdeen Royal Infirm, Dept Pathol, Aberdeen, Scotland

[11] Charleston Oncol, Canc Ctr, Charleston, SC USA

[12] Peking Univ, Beijing Canc Hosp, Dept Thorac Surg, Sch Oncol, Beijing, Peoples R China

[13] Bristol Myers Squibb, Immunooncol & Immunosci, Bristol, NJ USA

[14] Bristol Myers Squibb, Oncol Clin Sci, Princeton, NJ USA

[15] Bristol Myers Squibb, Translat Med, Bristol, NJ USA

[16] Bristol Myers Squibb, GBDS, Bristol, NJ USA

[17] Hosp Univ Puerta Hierro, Med Oncol, Madrid, Spain

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.09.739

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1261O

引用

页码：S731 / S731

页数：1